Myasthenic crisis is a life-threatening complication of myasthenia gravis. It’s when the muscles that you use to breathe get so weak that you can’t get air in and out of your lungs.

When the muscles needed for breathing are affected, a patient is said to be in myasthenic crisis. This is a life-threatening situation. Though anyone can get myasthenia gravis, those most likely ...

The drug industry witnessed major policy changes during Joe Biden's four-year term as U.S. President, including the historic ...

The Muscular Dystrophy Association (MDA)’s Kickstart program has announced receipt of both U.S. orphan drug and rare pediatric disease designations in support of work for congenital myasthenic ...

Myasthenia gravis and the Lambert–Eaton myasthenic syndrome (LEMS) are two autoimmune neuromuscular junction disorders to consider in this case. Myasthenia gravis is caused by antibodies against ...

It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome. Revenue Growth: Over the 3 months period, Catalyst ...

Truist Financial analyst Joon Lee reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report) today and set a price target of ...

One participant in the inebilizumab group died of septic shock and pneumonitis, which may have been due to acute respiratory syndrome caused by myasthenic crisis. In the placebo group, two ...

Catalyst stock gains on strong third-quarter results, beating earnings and revenue estimates, primarily driven by Firdapse ...

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on Catalyst Pharma (CPRX – Research Report). The associated price ...

GSK acquired an experimental therapy from Chimagen Biosciences, paying $300 million upfront for the “T-cell engager” therapy, ...

Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Thank you for standing by. My name is Kris and I will be your ...